blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1490398

EP1490398 - TUMOUR ASSOCIATED ANTIGENS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.08.2012
Database last updated on 11.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ISIS INNOVATION LIMITED
Ewert House, Ewert Place Summertown, Oxford
Oxfordshire OX2 7BZ / GB
[N/P]
Former [2005/01]For all designated states
Isis Innovation Limited
Ewert House, Ewert Place
Summertown, Oxford, Oxfordshire OX2 7BZ / GB
Inventor(s)01 / BANHAM, Alison, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501
John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
02 / PULFORD, Karen, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501
John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
03 / ANDERSON, Amanda, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501
John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
04 / GUINN, Barbara, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501
John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
 [2011/36]
Former [2005/01]01 / BANHAM, Alison, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501, John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
02 / PULFORD, Karen, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501, John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
03 / LIGGINS, Amanda, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501, John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
04 / GUINN, Barbara, Nuffield Dept Clinical Lab. Sci.
Level 5, Room 5501, John Radcliffe Hospital
Headington, Oxford OX3 9DU / GB
Representative(s)Baldock, Sharon Claire, et al
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [2005/01]Baldock, Sharon Claire, et al
BOULT WADE TENNANT, Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date03722712.127.03.2003
[2005/01]
WO2003GB01378
Priority number, dateGB2002000725127.03.2002         Original published format: GB 0207251
[2005/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03082916
Date:09.10.2003
Language:EN
[2003/41]
Type: A2 Application without search report 
No.:EP1490398
Date:29.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Type: B1 Patent specification 
No.:EP1490398
Date:05.10.2011
Language:EN
[2011/40]
Search report(s)International search report - published on:EP18.03.2004
ClassificationIPC:C07K14/47
[2005/01]
CPC:
C07K14/4722 (EP); A61K39/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
TitleGerman:TUMOR ASSOZIIERTE ANTIGENE[2005/01]
English:TUMOUR ASSOCIATED ANTIGENS[2005/01]
French:ANTIGENES ASSOCIES A UNE TUMEUR[2005/01]
Entry into regional phase27.10.2004National basic fee paid 
27.10.2004Designation fee(s) paid 
27.10.2004Examination fee paid 
Examination procedure27.10.2004Examination requested  [2004/53]
08.02.2006Despatch of a communication from the examining division (Time limit: M04)
09.06.2006Reply to a communication from the examining division
27.03.2008Despatch of a communication from the examining division (Time limit: M04)
01.08.2008Reply to a communication from the examining division
16.04.2009Despatch of a communication from the examining division (Time limit: M06)
26.10.2009Reply to a communication from the examining division
24.03.2011Communication of intention to grant the patent
28.07.2011Fee for grant paid
28.07.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.02.2006
Opposition(s)06.07.2012No opposition filed within time limit [2012/37]
Fees paidRenewal fee
24.03.2005Renewal fee patent year 03
23.03.2006Renewal fee patent year 04
28.03.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
30.03.2009Renewal fee patent year 07
24.03.2010Renewal fee patent year 08
28.03.2011Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.03.2003
AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
PT06.02.2012
LU27.03.2012
MC31.03.2012
[2014/34]
Former [2014/27]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
PT06.02.2012
LU27.03.2012
MC31.03.2012
Former [2014/21]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
PT06.02.2012
MC31.03.2012
Former [2013/29]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
PT06.02.2012
MC31.03.2012
Former [2013/22]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
PT06.02.2012
MC31.03.2012
Former [2013/07]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
PT06.02.2012
MC31.03.2012
Former [2012/47]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
PT06.02.2012
MC31.03.2012
Former [2012/37]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
PT06.02.2012
Former [2012/36]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
NL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
BG05.01.2012
GR06.01.2012
PT06.02.2012
Former [2012/35]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
NL05.10.2011
SE05.10.2011
SI05.10.2011
BG05.01.2012
GR06.01.2012
PT06.02.2012
Former [2012/34]BE05.10.2011
CY05.10.2011
CZ05.10.2011
NL05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
PT06.02.2012
Former [2012/28]BE05.10.2011
CY05.10.2011
NL05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
PT06.02.2012
Former [2012/24]BE05.10.2011
NL05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
PT06.02.2012
Former [2012/23]BE05.10.2011
NL05.10.2011
SI05.10.2011
GR06.01.2012
PT06.02.2012
Former [2012/21]BE05.10.2011
SI05.10.2011
Former [2012/11]SI05.10.2011
Cited inInternational search[X]US5922566  (BANDMAN OLGA [US], et al);
 [X]WO0162917  (LUDWIG INST CANCER RES [US]);
 [PX]WO03011902  (KENTON S R L [IT], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.